These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25896109)

  • 1. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
    Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
    J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Correa ZM
    Exp Eye Res; 2016 Jul; 148():30-32. PubMed ID: 27181224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
    Manna S; Caixeta Faraj RQ; Riemann B; Rao MB; Nair V; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
    Exp Eye Res; 2021 Apr; 205():108505. PubMed ID: 33617850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous.
    Manna S; Donnell AM; Faraj RQC; Riemann BI; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
    Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
    Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes.
    Manna S; Augsburger JJ; Correa ZM; Al-Rjoub MF; Rao MB; Banerjee RK
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):583-594. PubMed ID: 27754738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study.
    Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
    De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
    Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.
    Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A
    Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polylactic acid for visualizing the vitreous body during vitrectomy.
    Yamashita T; Sakamoto T; Yamakiri K; Miura M; Enaida H; Ueno A; Atsumi I; Matsuhisa K; Sakamoto Y; Kida T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3277-82. PubMed ID: 17591899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
    Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants.
    Morita Y; Ohtori A; Kimura M; Tojo K
    Biol Pharm Bull; 1998 Feb; 21(2):188-90. PubMed ID: 9514619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.